Summary
Overview
Work History
Education
Skills
Core Competencies
Websites
Patents
Google Scholar
Awards
Publications
References
Personal Information
Timeline
PRIYANKA DAHIYA

PRIYANKA DAHIYA

Cambridge

Summary

Accomplished molecular and cellular immunologist with expertise in medically relevant biology, immune-cell signaling, and host–pathogen interactions. Translates complex scientific insights into actionable strategies that enhance product development and cross-functional collaboration. Synthesizes multi-omic datasets and shapes scientific narratives to align research with business priorities, supported by a strong publication record and multiple patents.

Overview

8
8
years of professional experience

Work History

PhD Researcher, Molecular Cell Biology & Immunology

Centre for DNA Fingerprinting and Diagnostics
Hyderabad
07.2017 - 08.2025
  • Led a multi-platform research program investigating how Mycobacterium tuberculosis manipulates macrophage signaling to promote persistence.
  • Designed and executed experiments across molecular, cellular, biochemical, and in vivo systems to uncover mechanisms of immune evasion and identify therapeutic opportunities.
  • Discovered that the Mtb effector PE11 disrupts the FLCN–TFEB signaling axis, impairing autophagy and lysosomal biogenesis, revealing a novel mechanism of immune modulation relevant to chronic inflammatory and oncology-adjacent pathways.
  • Demonstrated PE11's role in enhancing inflammatory signaling and cytokine dysregulation through RNA-seq profiling, informing host-directed therapeutic strategies.
  • Established the enzymatic activity of PE11 and linked it to bacterial cell wall remodeling using biochemical assays and electron microscopy.
  • Contributed to small-molecule screening efforts, identifying candidate inhibitors validated in Mtb and MDR-Mtb infection models.
  • Supported development of a host-directed therapeutic approach that improved bacterial clearance and reduced reliance on antibiotics.
  • Collaborated with cross-disciplinary teams to integrate imaging, transcriptomics, and biochemical data into cohesive mechanistic models, advancing research objectives.
  • Produced scientific documents including manuscripts, reviews, and grant-ready materials, contributing to knowledge dissemination and funding efforts.
  • Presented research findings at national scientific conferences and workshops.
  • Trained junior researchers on laboratory techniques and best practices.

Education

Ph.D. - Molecular Cell Biology & Immunology

Centre for DNA Fingerprinting and Diagnostics (CDFD), India
01.2025
Thesis: Structural and functional characterization of Mycobacterium tuberculosis esterase PE11

M.Sc. - Biotechnology

University of Mysore, India
01.2015

B.Sc. - Botany, Zoology, Chemistry & Biotechnology

HNB Garhwal University, India
01.2013

Skills

  • Immunology
  • Host–pathogen interactions
  • Molecular biology
  • Tissue analysis
  • Mammalian cell culture
  • Infection models
  • Macrophage/T-cell biology
  • In vivo models
  • Cloning
  • Mutagenesis
  • PCR/qPCR
  • NGS prep
  • Protein expression
  • Purification
  • Biochemical assays
  • High-parameter flow cytometry
  • Confocal imaging
  • IP, IV, SC injections
  • Tissue processing
  • RNA-seq analysis
  • Data visualization
  • FlowJo
  • GraphPad Prism
  • ImageJ
  • Assay troubleshooting
  • Workflow optimization
  • Scientific writing
  • Technical writing
  • Data decision-making
  • Team collaboration

Core Competencies

Immunology, oncology-relevant biology, host–pathogen interactions, High-parameter flow cytometry, confocal imaging, tissue analysis, Molecular biology (PCR, qPCR, cloning, mutagenesis, NGS prep), Protein expression, purification, biochemical assays, Mammalian cell culture, infection models, macrophage/T-cell biology, In vivo models: IP/IV/ICV injections, tissue processing, Customer-centric solution development, Translating scientific insights into product strategy, Competitive landscape analysis, Cross-functional collaboration (R&D, commercial, digital, manufacturing), Data-driven decision-making and performance monitoring, Scientific communication for diverse audiences, Workflow optimization and assay troubleshooting, FlowJo, GraphPad Prism, ImageJ, RNA-seq analysis, Data visualization and interpretation, SOP development, documentation, data organization

Patents

  • Therapeutics for tuberculosis-associated liver pathology, Indian Patent: 202441081358
  • Host-directed TB therapeutics to improve immune responses and drug efficacy, Indian Patent: 202441058271

Google Scholar

https://scholar.google.com/citations?user=HtefGMgAAAAJ&hl=en

Awards

  • International Travel Award, Anusandhan National Research Foundation, 2025
  • Carl Storm International Diversity Fellowship, Gordon Research Conference, 2025
  • Young Scientist Award Finalist, Indian Immunology Society 2022, 2023
  • JRF + SRF Fellowship, DBT, Government of India (2017- 2022)
  • MSc Biotechnology Fellowship, DBT (2013-2015)
  • Summer Research Fellowship, Indian Academies of Sciences, 2014

Publications

Borah S, Dahiya P, Gupta R, Barman P, Valluri V, Mukhopadhyay S., PE11   protein of Mycobacterium tuberculosis is associated with increased   inflammation and fibrosis in liver. (in Communication)

Bisht MK, Maurya V, Dahiya P, Valluri VL, Ghosh S, Mukhopadhyay S. The PPE2 protein of   Mycobacterium tuberculosis is responsible for the development of   hyperglycemia and insulin resistance during tuberculosis. eLife 15:RP109532 https://doi.org/10.7554/eLife.109532.1

Dahiya P, Bisht MK, Saha   A, Chandramouli A, Kamat SS, Nandikoori VK, Ghosh S, Mukhopadhyay S. PE11   promotes intracellular persistence of Mycobacterium tuberculosis by   inhibiting autophagy and lysosomal biogenesis by targeting the   FLCN-lactate-TFEB signaling axis.  bioRxiv 2025.07.31.668032; doi: https://doi.org/10.1101/2025.07.31.668032

Dahiya P, Bisht MK, Mukhopadhyay S. Role of PE family of   proteins in mycobacterial virulence: Potential on anti-TB vaccine and drug   design. Int Rev   Immunol. 2025 Jan 31:1-16. doi: 10.1080/08830185.2025.2455161. Epub ahead of   print. PMID: 39889764.

Dahiya P, Banerjee A, Saha A,   Nandicoori VK, Ghosh S, Mukhopadhyay S. Structure-function relationship of   PE11 esterase of Mycobacterium tuberculosis with respect to its role   in virulence. Biochem Biophys Res Commun. 2024 Dec 20;739:150927. Epub   2024 Nov 10. PMID: 39541926. https://doi: 10.1016/j.bbrc.2024.150927

Bisht   MK, Dahiya P, Ghosh S, Mukhopadhyay S. The cause-effect   relation of tuberculosis on incidence of diabetes mellitus. Front Cell   Infect Microbiol. 2023 Jun 26;13:1134036. doi:10.3389/fcimb.2023.1134036.   PMID: 37434784; PMCID: PMC10330781.

Bisht   MK, Pal R, Dahiya P, Naz S, Sanyal P, Nandicoori VK, Ghosh S,   Mukhopadhyay S. The PPE2 protein of Mycobacterium tuberculosis is   secreted during infection and facilitates mycobacterial survival inside the   host. Tuberculosis (Edinb). 2023 Dec;143:102421.   doi:10.1016/j.tube.2023.102421. Epub 2023 Oct 12. PMID: 37879126.

Ananda AP, Manukumar HM, Umesha S, Soumya G, Priyanka D, et al. A   Relook at Food Packaging for Cost Effective by Incorporation of Novel   Technologies. J Packag Technol Res. 2017;1(2):67-85. doi:10.1007/s41783-017-0011-4

References

Available upon request.

Personal Information

Authorized To Work: U.S.

Timeline

PhD Researcher, Molecular Cell Biology & Immunology - Centre for DNA Fingerprinting and Diagnostics
07.2017 - 08.2025
Centre for DNA Fingerprinting and Diagnostics (CDFD) - Ph.D., Molecular Cell Biology & Immunology
University of Mysore - M.Sc., Biotechnology
HNB Garhwal University - B.Sc., Botany, Zoology, Chemistry & Biotechnology
PRIYANKA DAHIYA